Limited Immunogenicity of HIV CD8⁺ T-Cell Epitopes in Acute Clade C Virus Infection
Background. Human immunodeficiency virus type 1 (HlV-1)-specific CD8⁺ responses contribute to the decline in acute peak viremia following infection. However, data on the relative immunogenicity of CD8⁺ T-cell epitopes during and after acute viremia are lacking. Methods. We characterized CD8⁺ T-cell...
Saved in:
Published in | The Journal of infectious diseases Vol. 204; no. 5; pp. 768 - 776 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.09.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background. Human immunodeficiency virus type 1 (HlV-1)-specific CD8⁺ responses contribute to the decline in acute peak viremia following infection. However, data on the relative immunogenicity of CD8⁺ T-cell epitopes during and after acute viremia are lacking. Methods. We characterized CD8⁺ T-cell responses in 20 acutely infected, antiretro viral-naive individuals with HIV-1 subtype C infection using the interferon-γ enzyme-linked immunosorbent spot assay. Eleven of these had not fully seroconverted at the time of analysis. Viruses from plasma were sequenced within defined cytotoxic T-lymphocyte (CTL) cell epitopes for selected subjects. Results. At approximately 28 days after estimated initial infection, CD8⁺ T-cell responses were directed against an average of 3 of the 410 pep tides tested (range, 0-6); 2 individuals had no detectable responses at this time. At 18 weeks, the average number of peptides targeted had increased to 5 (range 0-11). Of the 56 optimal Gag CTL epitopes sequenced, 31 were wild-type in the infecting viruses, but only 11 of 31 elicited measurable CD8⁺ T-cell responses. Conclusions. These data demonstrate that the majority of CD8⁺ responses are not elicited during acute HIV infection despite the presence of the cognate epitope in the infecting strain. There is a need to define factors that influence lack of induction of effective immune responses and the parameters that dictate immunodominance in acute infection. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Presented in part: HIV Vaccines Keystone conference (X5), Banff, Alberta, Canada, 21–26 March 2010, Poster 244; and the HIV Acute Infection Meeting, Boston, MA, 22–23 September 2009. Potential conflicts of interested: none reported. |
ISSN: | 0022-1899 1537-6613 1537-6613 |
DOI: | 10.1093/infdis/jir394 |